Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Preoperative airway colonization prior to transthoracic esophagectomy predicts postoperative pulmonary complications.

Bludau M, Hölscher AH, Bollschweiler E, Leers JM, Gutschow CA, Brinkmann S, Schröder W.

Langenbecks Arch Surg. 2015 Aug;400(6):707-14. doi: 10.1007/s00423-015-1326-7. Epub 2015 Aug 8.

PMID:
26252998
2.
3.

Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.

Berlth F, Mönig S, Pinther B, Grimminger P, Maus M, Schlösser H, Plum P, Warnecke-Eberz U, Harismendy O, Drebber U, Bollschweiler E, Hölscher A, Alakus H.

Ann Surg Oncol. 2015 Jul 17. [Epub ahead of print]

PMID:
26183839
4.

Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment.

Bollschweiler E, Hölscher AH, Schmidt M, Warnecke-Eberz U.

Chin J Cancer Res. 2015 Jun;27(3):221-30. doi: 10.3978/j.issn.1000-9604.2015.04.04. Review.

5.

Molecular markers predicting lymph node metastasis in early esophageal cancer.

Plum PS, Warnecke-Eberz U, Dhaouadi O, Alakus H, Drebber U, Metzger R, Prenzel KL, Hölscher AH, Bollschweiler E.

Histol Histopathol. 2015 Apr 14:11618. [Epub ahead of print]

PMID:
25869644
6.

Prognostic impact of blood biomarkers TS and DPD in neoadjuvant-treated esophageal cancer patients.

Grimminger PP, Maus MK, Bergenthal J, Wandhöfer C, Fetzner UK, Herbold T, Bollschweiler E, Hölscher AH, Brabender J.

Anticancer Res. 2015 Mar;35(3):1297-302.

PMID:
25750278
7.

Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.

Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.

Tumour Biol. 2015 Jun;36(6):4643-53. doi: 10.1007/s13277-015-3112-0. Epub 2015 Jan 29.

PMID:
25631748
8.

Effect of laparoscopic antireflux surgery on esophageal motility.

Fuchs HF, Gutschow CA, Brinkmann S, Herbold T, Bludau M, Schröder W, Bollschweiler E, Hölscher AH, Leers JM.

Dig Surg. 2014;31(4-5):354-8. doi: 10.1159/000368662. Epub 2014 Dec 4.

PMID:
25503359
9.

Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.

Hölscher AH, Drebber U, Schmidt H, Bollschweiler E.

Ann Surg. 2014 Nov;260(5):779-84; discussion 784-5. doi: 10.1097/SLA.0000000000000964.

PMID:
25379849
10.

Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.

Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR.

Eur J Cancer. 2014 Nov;50(17):2950-7. doi: 10.1016/j.ejca.2014.08.020. Epub 2014 Oct 9.

PMID:
25307749
11.

Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort.

Hein R, Köster I, Bollschweiler E, Schubert I.

Scand J Gastroenterol. 2014 Nov;49(11):1325-35. doi: 10.3109/00365521.2014.962605. Epub 2014 Sep 26.

PMID:
25259808
12.

Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.

Alakus H, Bollschweiler E, Hölscher AH, Warnecke-Eberz U, Frazer KA, Harismendy O, Lowy AM, Mönig SP, Eberz PM, Maus M, Drebber U, Siffert W, Metzger R.

Ann Surg Oncol. 2014 Dec;21(13):4375-82. doi: 10.1245/s10434-014-3843-y. Epub 2014 Jul 2.

PMID:
24986238
13.

Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.

Berlth F, Mönig SP, Schlösser HA, Maus M, Baltin CT, Urbanski A, Drebber U, Bollschweiler E, Hölscher AH, Alakus H.

Anticancer Res. 2014 Jul;34(7):3313-20.

PMID:
24982335
14.

What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy.

Kutup A, Nentwich MF, Bollschweiler E, Bogoevski D, Izbicki JR, Hölscher AH.

Ann Surg. 2014 Dec;260(6):1016-22. doi: 10.1097/SLA.0000000000000335.

PMID:
24950288
15.

Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value.

Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S.

World J Gastroenterol. 2014 May 21;20(19):5679-84. doi: 10.3748/wjg.v20.i19.5679. Review.

16.

Treatment of early gastric cancer in the Western World.

Bollschweiler E, Berlth F, Baltin C, Mönig S, Hölscher AH.

World J Gastroenterol. 2014 May 21;20(19):5672-8. doi: 10.3748/wjg.v20.i19.5672. Review.

17.

[Quality of life and visceral surgery].

Bollschweiler E, Baltin C, Berlth F, Mönig SP, Hölscher AH.

Chirurg. 2014 Mar;85(3):203-7. doi: 10.1007/s00104-013-2602-0. Review. German.

PMID:
24464336
18.

Reply to letter: "significance of lymphadenectomy in ypT0N0M0R0 esophageal cancer".

Hölscher AH, Bollschweiler E.

Ann Surg. 2014 Apr;259(4):e68. doi: 10.1097/SLA.0000000000000365. No abstract available.

PMID:
24253158
19.

Extracapsular lymph node spread as a negative prognostic factor of adenocarcinoma of the pancreas and cancer of the papilla of vater.

Prenzel KL, Hölscher AH, Drebber U, Bollschweiler E, Gutschow CA, Stippel DL, Mönig SP.

Pancreas. 2014 Jan;43(1):64-8. doi: 10.1097/MPA.0b013e3182a44a91.

PMID:
24212239
20.

Frequency of lymph node metastasis in submucosal esophageal cancer.

Hölscher AH, Bollschweiler E.

Ann Surg. 2014 Jun;259(6):e84. doi: 10.1097/SLA.0000000000000298. No abstract available.

PMID:
24169170
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk